Výsledky vyhledávání

Akademický článek

Determinants of basal metabolic rate in Indian obese patients

Autor: Syngle, Vijaita

Publikováno v: In Obesity Medicine March 2020 17

Akademický článek

Efficacy and tolerability of DPP4 inhibitor, teneligliptin, on autonomic and peripheral neuropathy in type 2 diabetes: an open label, pilot study.

Autor: Syngle, Ashit^1,2 (AUTHOR), Chahal, Simran³ (AUTHOR), Vohra, Kanchan³ (AUTHOR) kanchanvohra34@gmail.com

Publikováno v: Neurological Sciences. Apr2021, Vol. 42 Issue 4, p1429-1436. 8p. 2 Charts, 1 Graph.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Therapeutic potential of spironolactone in ankylosing spondylitis patients: Relation to disease activity and functional status

Autor: Pawan Krishan, Inderjeet Verma, Ashit Syngle

Publikováno v: Egyptian Rheumatologist, Vol 43, Iss 2, Pp 173-178 (2021)

Aim of the work: Spironolactone with its anti-inflammatory and immunomodulatory properties due to inhibition of nuclear factor kappa B could have a therapeutic potential in ankylosing spondylitis (AS). The aim was to study the impact of spironolacton

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c671006aafc0b1f5ebbc09eccc277489
http://www.sciencedirect.com/science/article/pii/S1110116420300855

Zobrazit plný text záznamu

Efficacy and tolerability of DPP4 inhibitor, teneligliptin, on autonomic and peripheral neuropathy in type 2 diabetes: an open label, pilot study

Autor: Simran Chahal, Kanchan Vohra, Ashit Syngle

Publikováno v: Neurological Sciences. 42:1429-1436

Diabetic neuropathy increases risk of cardiovascular disease, peripheral artery disease, foot amputation and overall mortality. Not only hyperglycaemia induced nerve damage is harder to repair using currently approved medications, but also, the use o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b1e1901d6b85a9e79f8eb04204b43ca
https://doi.org/10.1007/s10072-020-04681-2

Zobrazit plný text záznamu

Angiotensin-Receptor Blockade Improves Inflammation and Endothelial Dysfunction in Ankylosing Spondylitis: ARB-AS Study

Autor: Pawan Krishan, Nidhi Garg, Ashit Syngle

Publikováno v: Int J Angiol

Cardiovascular (CV) disease is the leading cause of premature death in ankylosing spondylitis (AS). Atherosclerosis and AS share similar pathogenic mechanisms. The proven benefits of angiotensin-receptor blockers (ARBs) in atherosclerotic cardiovascu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faf0de80f1b32c9de25577fc8efc86b3
https://pubmed.ncbi.nlm.nih.gov/34853573

Zobrazit plný text záznamu

Stimulation of endothelial progenitor cells: A new putative therapeutic effect of hmg co-a reductase inhibitor in ankylosing spondylitis: Stat-as study

Autor: D. Syngle, N. Garg

Publikováno v: Atherosclerosis. 355:252-253

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2602108933dac29c6b8d77dce1e42679
https://doi.org/10.1016/j.atherosclerosis.2022.06.963

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

POS0945 IMPROVEMENT OF ENDOTHELIAL DYSFUNCTION AND INFLAMMATION IN ANKYLOSING SPONDYLITIS: IMPROVE-AS STUDY

Autor: A. Syngle, N. Garg, P. Krishan, D. Syngle

Publikováno v: Annals of the Rheumatic Diseases. 81:776.2-777

BackgroundCardiovascular (CV) disease is the leading cause of death in Ankylosing Spondylitis (AS)1. The chronic inflammatory-driven endothelial dysfunction and accelerated atherosclerosis contribute to the enhanced CV risk in AS. However, the therap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::adfca3d0fcc5c7264dc759d0ddb70654
https://doi.org/10.1136/annrheumdis-2022-eular.3941

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání